**Core Concept**
Multiple myeloma is a plasma cell malignancy characterized by the proliferation of malignant plasma cells in the bone marrow, leading to various immunologic and clinical manifestations. The immunologic classification of multiple myeloma is based on the type of immunoglobulin produced by the malignant plasma cells.

**Why the Correct Answer is Right**
The most common immunologic type of multiple myeloma is IgG kappa. This type accounts for approximately 50% of all multiple myeloma cases and is characterized by the production of kappa light chains in the context of an IgG heavy chain. The production of IgG kappa leads to the accumulation of monoclonal IgG kappa in the serum, which can cause various clinical manifestations, including hypercalcemia, renal failure, and anemia.

**Why Each Wrong Option is Incorrect**
**Option A:** IgA lambda is a less common type of multiple myeloma, accounting for approximately 10% of cases. It is characterized by the production of lambda light chains in the context of an IgA heavy chain.
**Option B:** IgM kappa is a rare type of multiple myeloma, accounting for less than 5% of cases. It is characterized by the production of kappa light chains in the context of an IgM heavy chain.
**Option C:** IgD lambda is a rare type of multiple myeloma, accounting for less than 2% of cases. It is characterized by the production of lambda light chains in the context of an IgD heavy chain.

**Clinical Pearl / High-Yield Fact**
The classification of multiple myeloma into different immunologic types is essential for determining the prognosis and guiding treatment. IgG kappa multiple myeloma tends to have a better prognosis than other types, but it can still be challenging to treat.

**Correct Answer:** A. IgG kappa.